Search

Displaying results 9151 - 9160 of 10000 in total
  1. Drug

    TBA-7371

    go.drugbank.com/drugs/DB16243
    Investigational

    TBA-7371 is under investigation in clinical trial NCT04176250 (Early Bactericidal Activity of TBA-7371 in Pulmonary Tuberculosis).

  2. Drug

    STG-001

    go.drugbank.com/drugs/DB16734
    Investigational

    STG-001 is under investigation in clinical trial NCT04489511 (Study of STG-001 in Subjects With Stargardt Disease).

  3. Drug

    Zigakibart

    go.drugbank.com/drugs/DB18892
    Investigational

    Zigakibart is under investigation in clinical trial NCT05852938 (A Study of BION-1301 in Adults With Iga Nephropathy).

  4. Drug

    Ropanicant

    go.drugbank.com/drugs/DB19134
    Investigational

    Ropanicant is under investigation in clinical trial NCT06126497 (Study Evaluating Safety and Efficacy of Ropanicant in MDD Patients).

  5. Drug

    β-Methylfentanyl

    go.drugbank.com/drugs/DB09171
    ExperimentalIllicit

    β-Methylfentanyl is an analgesic of the _opioid_ class. It is an analog of the potent opioid, fentanyl.

  6. Drug

    Berkelium

    go.drugbank.com/drugs/DB12993
    Investigational

    Berkelium is under investigation in clinical trial NCT02189122 (Comparative Effects of Aspirin and NHP-544C).

  7. Drug

    Fialuridine

    go.drugbank.com/drugs/DB15427
    Investigational

    Fialuridine is under investigation in clinical trial NCT01337466 (Biodistribution and Dosimetry Evaluation of [124I]FIAU).

  8. Drug

    Imaradenant

    go.drugbank.com/drugs/DB16192
    Investigational

    Imaradenant is under investigation in clinical trial NCT03381274 (Oleclumab (MEDI9447) Egfrm NSCLC Novel Combination Study).

  9. Drug

    DNL343

    go.drugbank.com/drugs/DB18678
    Investigational

    DNL343 is under investigation in clinical trial NCT05842941 (HEALEY ALS Platform Trial - Regimen G DNL343).

  10. Drug

    CVN-424

    go.drugbank.com/drugs/DB18958
    Investigational

    CVN-424 is under investigation in clinical trial NCT06006247 (Early Parkinson's Disease Monotherapy With CVN424).